Is Entero Therapeutics, Inc. (ENTO) a Buy, Sell, or Hold?
NASDAQ : ENTO
Entero Therapeutics, Inc. — Institutional Ownership
$2.85 USD
-$0.15 (-5.0%)
- Volume
- 93.18K
- Average Volume
- 216.27K
- Market Capitalization
- $13.58M
- P/E Ratio
- -0.70
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $5.84
- Year Low
- $0.97
- Day High
- —
- Day Low
- —
- Payout Ratio
- -$0.04
- Current Ratio
- $0.16
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-08 | Jason David Sawyer | 540K | 7.10% |
| 2026-02-12 | Renaissance Technologies LLC | 31000.0 | 0.92% |
| 2026-01-13 | Strategic EP, LLC | 209.54K | 5.00% |
| 2025-11-13 | Renaissance Technologies LLC | 86400.0 | 5.44% |
| 2025-06-10 | Arif Ali IRA Roth | 147.9K | 3.10% |
| 2025-06-10 | ANANRA LLC TRUST | 20200.0 | 0.40% |
| 2025-06-10 | ANARP LLC | 62800.0 | 1.30% |
| 2025-06-10 | Ali Arif Nasir | 230.9K | 4.90% |
| 2025-06-09 | Ali Arif Nasir | 250.9K | 5.30% |
| 2025-06-09 | Arif Ali IRA Roth | 147.9K | 3.10% |
| 2025-06-09 | ANARP LLC | 82800.0 | 1.70% |
| 2025-06-09 | ANANRA LLC TRUST | 20200.0 | 0.40% |
| 2023-02-14 | Steven Boyd | 740.4K | 9.99% |
| 2023-02-14 | Armistice Capital, LLC | 740.4K | 9.99% |
| 2020-02-14 | Laurence W. Lytton | - | 0.00% |
| 2018-05-11 | Laurence W. Lytton | 1.03M | 6.15% |
ENTO Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $4.66 | 1.62M | $7.53M | $899.78K | $2.16M | $8.8M |
| 2024-12-31 | $1.87 | 4.65M | $8.7M | $163.48K | $140.53K | $8.68M |
| 2023-12-31 | $12.60 | 336.34K | $4.24M | $3.71M | $826.84K | $1.35M |
| 2022-12-31 | $367.92 | 35912 | $13.21M | $1.36M | $883.7K | $12.73M |
| 2021-12-31 | $18207.00 | 2125 | $38.69M | $8.25M | $1.03M | $31.47M |
| 2020-12-31 | $122220.00 | 677 | $82.74M | $6.06M | $628.94K | $77.31M |
| 2019-12-31 | $131040.00 | 533 | $69.84M | $175.8K | $1.6M | $71.27M |
| 2018-12-31 | $152460.00 | 367 | $55.95M | $1.11M | $255.03K | $55.09M |
| 2017-12-31 | $467460.00 | 253 | $118.27M | $573.47K | $416.54K | $118.11M |
| 2016-12-31 | $597240.00 | 154 | $91.97M | $1.77M | $155.19K | $90.36M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2.85 | 4.45M | $12.69M | $385.54K | $2.49M | $14.79M |
| 2025-12-31 | $4.66 | 1.62M | $7.53M | $899.78K | $2.16M | $8.8M |
| 2025-09-30 | $5.00 | 1.65M | $8.26M | $2.52M | $835.61K | $6.58M |
| 2025-06-30 | $1.20 | 4.76M | $5.72M | $4474 | $835.61K | $6.55M |
| 2025-03-31 | $1.44 | 4.77M | $6.86M | $59352 | $835.61K | $7.64M |
| 2024-12-31 | $1.87 | 4.75M | $8.89M | $163.48K | $140.53K | $8.87M |
| 2024-09-30 | $1.03 | 4.55M | $4.69M | $366.79K | $159.67K | $4.48M |
| 2024-06-30 | $3.36 | 2.29M | $7.71M | $662.48K | $356.03K | $7.4M |
| 2024-03-31 | $12.72 | 1.76M | $22.41M | $3.43M | $6.98M | $25.96M |
| 2023-12-31 | $12.60 | 357.32K | $4.5M | $3.71M | $826.84K | $1.62M |
| 2023-09-30 | $17.40 | 378.3K | $6.58M | $3.29M | $231.29K | $3.52M |
| 2023-06-30 | $96.00 | 113.55K | $10.9M | $1.24M | $401.7K | $10.07M |